|Splenic Infarcts and Pulmonary Emboli: The Thromboembolic Potential of Covid-19
|K. Elkholy, A. Antonenko, A. Gabr, N. McEvoy, D. O’Keeffe, M. O’Connor
|University Hospital Limerick
|Click to view poster
|Incidence of thromboembolic disease is reported to be high in SARS-CoV2 disease and is seen in a multitude of organ systems ranging from cutaneous thrombosis to pulmonary embolism, stroke or coronary thrombosis sometimes with catastrophic outcomes.
Evidence points towards a key role of thromboembolism, hypercoagulability and over production of proinflammatory cytokines mimicking a “cytokine storm” which leads to multiorgan failure. 
Here, we report a case of pulmonary Covid-19 infection with acute splenic infarcts and pulmonary emboli. We believe this is potentially among the first published cases to include contrast-enhanced imaging of splenic infarcts in this condition. There is a growing body of published evidence that complications of Covid-19 are not limited to the pulmonary system.  To our knowledge, this is the first reported clinical image case of Covid-19-related splenic infarcts.